Fig. 3.

Advanced basal cell carcinoma (BCC): complete and sustained tumor clearance. Posterior (A) and lateral (B) views of the left upper back of a 62-year-old man demonstrates clearance of the advanced BCC. He concurrently received vismodegib and a total of four doses of nivolumab; the latter was discontinued because of a skin rash and recurrent transaminitis, and the former was stopped after 8.5 months because of appetite loss. Multiple skin biopsies confirmed complete and sustained remission after 5 months of treatment. He has remained in complete remission for 68.5 months (though therapy was stopped ~ 60 months earlier). Republished from [73] with permission from Elsevier